Bulevirtide Reduces Hepatitis D Viral Load
Data from an ongoing study in patients with compensated cirrhosis and clinically significant portal hypertension have raised hope for an emerging treatment option in this rare, deadly disease.
United States Maggiore Policlinico Bulevirtide Hepcludex Marc Bourli International Liver Congress Elisabetta Degasperi
Source: medscape.com